Cryptococcosis in China (1985-2010): Review of Cases from Chinese Database

Mycopathologia

Volumn 173, Issue 5-6, 2012, Pages 329-335

  Yuchong, Chen ^a,b   Fubin, Che ^b   Jianghan, Chen ^b   Fenglian, Wei ^b   Nan, Xu ^b   Minghui, Yang ^b   Yalin, Sun ^c   Zhizhong, Zheng ^a  

^a FUDAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acquired immune deficiency syndrome (AIDS); Amphotericin B; Cryptococcus; Meningitis

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; CHINA; CRYPTOCOCCOSIS; DRUG COMBINATION; FACTUAL DATABASE; HUMAN; IMMUNOCOMPROMISED PATIENT; META ANALYSIS; METHODOLOGY; MORTALITY; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; CHINA; CRYPTOCOCCOSIS; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOCOMPROMISED HOST; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84860586453     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9471-1     Document Type: Article

References (13)

1. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010; 50: 291-322.
2. Subramanian S, Mathai D. Clinical manifestations and management of cryptococcal infection. J Postgrad Med. 2005; 51: S21-6.
3. Tay ST, Rohani MY, Soo Hoo TS, et al. Epidemiology of cryptococcosis in Malaysia. Mycoses. 2009; 53: 509-14.
4. Tintelnot K, Lemmer K, Losert H, et al. Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates. Mycoses. 2004; 47: 455-64.
5. Friedman GD, Jeffrey Fessel W, Udaltsova NV, et al. Cryptococcosis: the 1981-2000 epidemic. Mycoses. 2005; 48: 122-5.
6. Chayakulkeeree M, Perfect JR. Cryptococcosis. In: Duane RH, Michael GR, editors. Diagnosis and treatment of human mycoses. Totowa, New Jersey: Humana Press; 2008. p. 255-77.
7. Wu SX, Guo NR, Li XF, et al. Human pathogenic fungi in China-emerging trends from ongoing national survey for 1986, 1996, and 2006. Mycopathologia. 2011; 171: 387-93.
8. Seboxa T, Alemu S, Assefa A, et al. Cryptococcal meningitis in patients with acquired immunodeficiency syndrome in prehaart era at Gondar College of Medical Sciences Hospital north-west Ethiopia. Ethiop Med J. 2010; 48: 237-41.
9. Bennett JE, Dismukes W, Duma RJ, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med. 1979; 301: 126-31.
10. Jongwutiwes U, Kiertiburanakul S, Sungkanuparph S. Impact of antiretroviral therapy on the relapse of cryptococcosis and survival of HIV-infected patients with cryptococcal infection. Curr HIV Res. 2007; 5: 355-60.
11. Manosuthi W, Sungkanuparph S, Thongyen S, et al. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis. J Med Assoc Thai. 2006; 89: 795-802.
12. Tintelnot K, SchaÈr G, Polak A, et al. Epidemiological data of cryptococcosis in Austria, Germany and Switzerland: part of the ECMM survey in Europe. Mycoses. 2001; 44: 345-50.
13. Chen J, Wen H, Wu J, et al. Adverse effects of amphotericin B during treatment of cryptococcal meningitis and their management. Acad J Sec Mil Med Univ. 2005; 26: 456-7.